AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2024
May 8, 2024
3174_iss_2024-05-08_b69f3240-7f43-4f2f-88ae-00ccf96b0fea.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Moberg Pharma AB (publ)
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension
| Instrument | |
|---|---|
| Instrument | Aktier |
| Before the transaction | |
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification Share loan | |
| Date | 07/05/2024 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 1,371,624 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 1,371,624 |
| 4.8284 % |
|---|
| 0 % |
| 4.8284 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.8284 % | 1,371,624 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | 0.34958 % | 99,306 |
| Total | 5.17798 % | 1,470,930 |
Group total holdings
Voting rights 1,470,930 Percentage of voting rights 5.17798
Notes (other relevant informations according to law)
Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Angivet gränsvärde har underskridits på grund av utlåning av aktier.
Published
08/05/2024 10:26
Contact
Name Marie Karlsfeldt
Email [email protected]
*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13